Literature DB >> 28571561

High Sensitivity Troponin I and T Reflect the Presence of Obstructive and Multi-Vessel Coronary Artery Disease Being Assessed by Coronary Computed Tomography Angiography.

Nadine Reckord1, Michael Behnes2, Michèle Natale1, Agnibh Mukherji1, Jonas Rusnak1, Uzair Ansari1, Siegfried Lang1, Ursula Hoffmann1, Martin Borggrefe1, Thomas Henzler2, Michael Neumaier3, Maximilian T Kittel3, Kambis Mashayekhi4, Thomas Bertsch5, Ibrahim Akin1.   

Abstract

BACKGROUND: This study evaluates the association between high sensitivity troponin I (hsTnI) and T (hsTnT) in patients with suspected stable Coronary Artery Disease (CAD) undergoing Coronary Computed Tomography Angiography (CCTA).
METHODS: Patients undergoing CCTA were enrolled prospectively. CCTA was indicated in patients with angina and a low to intermediate pre-test probability for CAD during routine clinical care. Blood samples were taken at the time of CCTA to measure cardiac biomarkers.
RESULTS: A total of 99 patients were enrolled with 43 % revealing no CAD, 30 % with non-obstructive and 26 % with obstructive CAD. Out of these, 61 % had single-vessel and 39 % had multi-vessel CAD. Both hsTnI and hsTnT levels increased significantly according to the presence and extent of CAD (p = 0.0001) and were able to discriminate the presence of both obstructive (AUC range: 0.775 - 0.785; p = 0.0001) and multi-vessel CAD (AUC range: 0.740 - 0.749; p = 0.01). In multivariate logistic regression models adjusted for cardiovascular risk factors and NT-proBNP, both hsTn were still associated significantly with obstructive CAD (range of odds ratios (OR): 8.3-32.3; p < 0.02). DISCUSSION: This study shows that high sensitivity troponin I and T reflect the presence and extent of CAD being diagnosed by CCTA in patients with a low to intermediate pretest probability for CAD. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Blood sampling; computed tomography; coronary artery disease; data analysis; high sensitivity troponin

Mesh:

Substances:

Year:  2017        PMID: 28571561     DOI: 10.2174/1389201018666170601082145

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  4 in total

1.  NCF2, MYO1F, S1PR4, and FCN1 as potential noninvasive diagnostic biomarkers in patients with obstructive coronary artery: A weighted gene co-expression network analysis.

Authors:  Xian-Gang Mo; Wei Liu; Yao Yang; Saber Imani; Shan Lu; Guorong Dan; Xuqiang Nie; Jun Yan; Rixing Zhan; Xiaohui Li; Youcai Deng; Bingbo Chen; Yue Cai
Journal:  J Cell Biochem       Date:  2019-06-27       Impact factor: 4.429

2.  Use of High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia: A Cohort Study.

Authors:  Muhammad Hammadah; Jeong Hwan Kim; Ayman Samman Tahhan; Bryan Kindya; Chang Liu; Yi-An Ko; Ibhar Al Mheid; Kobina Wilmot; Ronnie Ramadan; Ayman Alkhoder; Fahad Choudhary; Mohamad Mazen Gafeer; Naser Abdelhadi; Pratik Pimple; Pratik Sandesara; Bruno B Lima; Amit J Shah; Laura Ward; Michael Kutner; J Douglas Bremner; David S Sheps; Paolo Raggi; Laurence S Sperling; Viola Vaccarino; Arshed A Quyyumi
Journal:  Ann Intern Med       Date:  2018-11-06       Impact factor: 25.391

3.  Low- to high-density lipoprotein cholesterol ratio followed by coronary computed tomography angiography improves coronary plaque classification accuracy.

Authors:  Xiyang Hu; Wei Zhang; Nairui Zhao; Rongcheng Zhao; Shuofeng Li
Journal:  Oncotarget       Date:  2017-12-21

4.  Cardiac troponin I and T for ruling out coronary artery disease in suspected chronic coronary syndrome.

Authors:  Sjur H Tveit; Peder L Myhre; Tove Aminda Hanssen; Signe Helene Forsdahl; Amjid Iqbal; Torbjørn Omland; Henrik Schirmer
Journal:  Sci Rep       Date:  2022-01-18       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.